News & Press Releases

Mintz is pleased to announce that Intellectual Asset Management (IAM) named Michael Renaud, James Wodarski and Frank Gerratana to its 2022 edition of the IAM Strategy 300 Global Leaders Guide, a supplement to the IAM Strategy 300: The World’s Leading IP Strategists. According to IAM, the guide “draws from the worlds of private practice, consulting, and other service providers, with specialists from the major IP markets in North America, Europe and Asia. Together they possess a wealth of expertise across disciplines and sectors.”

As the pandemic and favorable market conditions drove record M&A and private equity dealmaking in 2021, Mintz’s Private Equity Practice handled a number of complex and impactful middle-market transactions for a growing number of private equity funds across the country spanning a variety of industries, including Charlesbank Capital Partners, DW Healthcare Partners, and Monomoy Capital Partners. In addition, the firm added several practitioners with extensive transactional knowledge to its deep bench to support private equity clients.

Mintz achieved a significant victory for BTA Bank (BTA) on January 18, when the U.S. Court of Appeals for the Second Circuit affirmed summary judgment dismissing all claims against BTA in a nearly decade-long securities fraud lawsuit alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. This decisive issue of what loss causation evidence a holder of thinly-traded securities must present to prove such claims was a matter of first impression in the Second Circuit.

Mintz is pleased to announce that Managing Member of the firm’s Los Angeles Office Joshua Briones and Member Arameh Z. O’Boyle have been named to the Los Angeles Business Journal’s (LABJ) 2022 “Minority Leaders of Influence: Attorneys” list. The annual list recognizes minority lawyers in the Los Angeles region and their careers, practice, and successes they’ve achieved.

Mintz is pleased to announce that William Kannel, Daniel Bleck, and Paul Ricotta have been named to the Lawdragon 500 Leading U.S. Bankruptcy and Restructuring Lawyers list, which honors attorneys who “dazzle in financial restructuring” and help distressed companies find financing and acquirers.

The deal will take public ProKidney, a leading clinical-stage cellular therapeutics company focused on chronic kidney disease, and is expected to provide up to $825 million in gross cash proceeds.